Frank G. Ondrey, MD, PhD

Clinic Number: 612-625-7400

Office address:
Head Neck Surgery Lions 5M International Hearing Center
Department of Otolaryngology
MMC 396
420 Delaware Street S.E.
Minneapolis, MN 55455

Email: ondre002@umn.edu

Undergraduate Education: Loyola University of Chicago
Medical School: Rush Medical College
Rush Presbyterian St. Lukes Medical Center Chicago IL
Residency: University of Minnesota (1989-1995)
Professional Experience: Senior Staff Surgeon, National Institutes of Health, Bethesda, MD (1995-98)
Consulting Otolaryngologist, Human Genome Project, Bethesda, MD (1995-98)
Year started in the department: 1998

Clinical Interests: Dr. Ondrey returned to the Otolaryngology Department from a Faculty Position at the National Institutes of Health to start a clinical trial program and laboratory in squamous cancer of the head and neck in addition to his clinical practice. He specifically treats patients with head and neck cancer and precursor lesions. He was involved in the design and implementation of clinical trials for early and advanced throat cancer at the NIH and is continuing these interests at the University of Minnesota. He recently co-authored a study in head and neck cancer that appears to double the survival of his advanced cancer patients at the NIH. He also treats patients in a comprehensive general otolaryngology practice for a full range of problems from difficult sinus infections and polyps, chronic ear infections, facial trauma, and throat problems such as hoarseness.

Research Interests: Dr. Ondrey directs the Molecular Oncology program of the University of Minnesota Otolaryngology department. In the last two years Dr. Ondrey’s lab work has resulted in reasearch funding from several sources. In October 2001, Dr. Ondrey’s laboratory work was funded as a clinical trial for oral cancer prevention by the National Cancer Institute in Washington, DC. Patients with precancerous lesions of their mouths and throats are encouraged to contact Dr. Ondrey or his associates if they are interested in involvement in clinical studies for oral cancer prevention.